US 10273307
Humanized anti-CD134 (OX40) antibodies and uses thereof
granted A61PA61P35/00A61P37/04
Quick answer
US patent 10273307 (Humanized anti-CD134 (OX40) antibodies and uses thereof) held by Biocerox Products B.V. expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Biocerox Products B.V.
- Grant date
- Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P35/00, A61P37/04